SCRI FCS South is a clinical research site located in Fort Myers, Florida, United States 33901.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
SCRI FCS South has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.
Sponsors: Daiichi Sankyo.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SCRI FCS South has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SCRI FCS South has 1 clinical trials on record, with 1 currently active. Their work covers HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.
SCRI FCS South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.